A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.

Mark Clemons,Dean Fergusson,Anil A. Joy,Judith Meza-Junco,Julie A. Price Hiller,John R. Mackey,Xiaofu Zhu,Mohammed Fk Ibrahim,Bassam Basulaiman,Arif Ali Awan,Marta Sienkiewicz,Lisa Vandermeer,Lacey D. Pitre,Nancy Alice Nixon,Brian Hutton,Gregory R. Pond,John Hilton

A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.

2020

Mark Clemons
Dean Fergusson
Anil A. Joy
Judith Meza-Junco
Julie A. Price Hiller
John R. Mackey
Xiaofu Zhu
Mohammed Fk Ibrahim
Bassam Basulaiman
Arif Ali Awan
Marta Sienkiewicz
Lisa Vandermeer
Lacey D. Pitre
Nancy Alice Nixon
Brian Hutton
Gregory R. Pond
John Hilton

7001Background: Docetaxel-cyclophosphamide (TC) adjuvant chemotherapy is commonly used in patients with early stage breast cancer (EBC). Due to the risk of febrile neutropenia (FN) with TC, primary...

Keywords:

Granulocyte
Colony-stimulating factor
Oncology
multicenter study
Internal medicine
in patient
Febrile neutropenia
Breast cancer
Cyclophosphamide
Pathology
Medicine
Antibiotics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations